Glioblastoma: An Update in Pathology, Molecular Mechanisms and Biomarkers
International Journal of Molecular Sciences · 06.03.2024 · 25 (5) · 3040
DOI: 10.3390/ijms25053040 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 06.03.2024. Verfasst von Zhong Lan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, School of Medicine, South China University of Technology, Guangzhou 510006, China. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Brain Neoplasms, Glioblastoma. Die Arbeit wurde bisher 141-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Glioblastoma multiforme (GBM) is the most common and malignant type of primary brain tumor in adults. Despite important advances in understanding the molecular pathogenesis and biology of this tumor in the past decade, the prognosis for GBM patients remains poor. GBM is characterized by aggressive biological behavior and high degrees of inter-tumor and intra-tumor heterogeneity. Increased understanding of the molecular and cellular heterogeneity of GBM may not only help more accurately define specific subgroups for precise diagnosis but also lay the groundwork for the successful implementation of targeted therapy. Herein, we systematically review the key achievements in the understanding of GBM molecular pathogenesis, mechanisms, and biomarkers in the past decade. We discuss the advances in the molecular pathology of GBM, including genetics, epigenetics, transcriptomics, and signaling pathways. We also review the molecular biomarkers that have potential clinical roles. Finally, new strategies, current challenges, and future directions for discovering new biomarkers and therapeutic targets for GBM will be discussed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, School of Medicine, South China University of Technology, Guangzhou 510006, China.
ORCID-Profile: Zhong Lan, Xiaoqin Zhang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Lan, Z., Li, X., & Zhang, X. (2024). Glioblastoma: An Update in Pathology, Molecular Mechanisms and Biomarkers. International Journal of Molecular Sciences, 25(5), 3040. https://doi.org/10.3390/ijms25053040
Vancouver
Lan Z, Li X, Zhang X. Glioblastoma: An Update in Pathology, Molecular Mechanisms and Biomarkers. International Journal of Molecular Sciences. 2024;25(5):3040. doi:10.3390/ijms25053040
BibTeX
@article{Lan2024,
author = {Lan, Zhong and Li, Xin and Zhang, Xiaoqin},
title = {Glioblastoma: An Update in Pathology, Molecular Mechanisms and Biomarkers},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {5},
pages = {3040},
doi = {10.3390/ijms25053040}
}
EUVIMED